Mubadala Capital logo

Mubadala Capital

Asia, Dubai, United Arab Emirates, Dubai

Description

Mubadala Capital manages investments across various asset classes, including private equity, public equity, credit, and venture capital.

Investor Profile

Mubadala Capital has backed more than 9 startups, with 6 new investments in the last 12 months alone. The firm has led 3 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Life Science, Therapeutics.
  • Led 2 rounds in the past year.

Stage Focus

  • Series A (44%)
  • Series B (22%)
  • Series C (11%)
  • Private Equity (11%)
  • Series Unknown (11%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Software
  • Medical
  • Health Care
  • Pharmaceutical
  • Machine Learning
  • Bioinformatics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mubadala Capital frequently co-invest with?

Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Qatar Investment Authority
Asia, Ad Dawhah, Qatar, Doha
Co-Investments: 2
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 1
Abstract Ventures
North America, California, United States, San Francisco
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
DCVC Bio
North America, California, United States, San Francisco
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

What are some of recent deals done by Mubadala Capital?

Anaconda

Austin, Texas, United States

Anaconda is an open-source distribution of the Python and R programming languages for data science that simplifies package management.

AnalyticsArtificial Intelligence (AI)Big DataCloud InfrastructureEnterprise SoftwareMachine LearningOpen Source
Series CJul 31, 2025
Amount Raised: $150,000,000
Light Horse Therapeutics

San Diego, California, United States

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Biotechnology
Series AJan 9, 2025
Amount Raised: $62,000,000
Tenvie Therapeutics

South San Francisco, California, United States

Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.

BiotechnologyMedicalNeuroscienceTherapeutics
Series AJan 8, 2025
Amount Raised: $200,000,000
nChroma Bio

Boston, Massachusetts, United States

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

BiotechnologyMedicalProduct Research
Series UnknownDec 11, 2024
Amount Raised: $75,000,000
Silver Rock Financial

Los Angeles, California, United States

Silver Rock Financial operates as an investment management company.

FinanceFinancial ServicesVenture Capital
Private EquityDec 5, 2024
GC Therapeutics

Boston, Massachusetts, United States

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

BiotechnologyLife ScienceTherapeutics
Series ASep 19, 2024
Amount Raised: $65,000,000
Outpace Bio

Seattle, Washington, United States

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

BiotechnologyHealth CareLife SciencePharmaceutical
Series BAug 1, 2024
Amount Raised: $144,000,000
Iambic Therapeutics

San Diego, California, United States

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics
Series BApr 24, 2024
Amount Raised: $50,000,000
Unlearn.AI

San Francisco, California, United States

Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.

Artificial Intelligence (AI)BioinformaticsClinical TrialsLife Science
Series CFeb 8, 2024
Amount Raised: $50,000,000
Andalusia Labs

San Francisco, California, United States

Andalusia Labs is developing the universal security layer for digital assets.

BlockchainFinTechSoftware
Series ADec 13, 2023
Amount Raised: $48,000,000